Oasis Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 10.20 Cr
as on 04-12-2024
- Company Age 44 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 2.00 M
as on 04-12-2024
- Revenue %
(FY 2022)
- Profit 46.63%
(FY 2022)
- Ebitda 46.63%
(FY 2022)
- Net Worth -0.34%
(FY 2022)
- Total Assets -0.00%
(FY 2022)
About Oasis Nutraceuticals
The Corporate was formerly known as Sam Leaseco Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 10.20 Cr.
The company currently has active open charges totaling ₹2.00 M.
Daksha Kakadiya, Vijay Wadekar, and Abhishek Ashar serve as directors at the Company.
- CIN/LLPIN
L51101MH1980PLC022765
- Company No.
022765
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Jun 1980
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oasis Nutraceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daksha Kakadiya  | Director | 26-Oct-2015 | Current |
| Vijay Wadekar | Additional Director | Current | |
| Abhishek Ashar | Additional Director | 25-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Oasis Nutraceuticals.
Oasis Nutraceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.63% increase in profit. The company's net worth dipped by a decrease of 0.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oasis Nutraceuticals?
In 2021, Oasis Nutraceuticals had a promoter holding of 1.32% and a public holding of 98.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jainex Compuware Manufacturing Private LimitedActive 33 years 8 months
Abhishek Ashar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 01 Sep 1992 | ₹2.00 M | Open |
How Many Employees Work at Oasis Nutraceuticals?
Unlock and access historical data on people associated with Oasis Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oasis Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oasis Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
